Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK/T-cell lymphoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 3, 2012, Pages 1115-1121

  Wang, Hua ^a,b   Li, Ye Xiong ^a   Wang, Wei Hu ^a   Jin, Jing ^a   Dai, Jian Rong ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Song, Yong Wen ^a   Wang, Zhao Yang ^a   Liu, Qing Feng ^a   Fang, Hui ^a   Qi, Shu Nan ^a   Liu, Xin Fan ^a   Yu, Zi Hao ^a  

^a CANCER HOSPITAL   (China)

^b Cancer Hospital of Jiangxi Province   (China)

Author keywords

IMRT; Intensity modulated radiotherapy; Nasal NK T cell lymphoma; Prognosis; Radiotherapy

Indexed keywords

COMBINATION CHEMOTHERAPY; DOSE-VOLUME HISTOGRAMS; DOSIMETRIC PARAMETER; HIGH DOSE; IMRT; INTENSITY-MODULATED RADIOTHERAPY; KAPLAN-MEIER METHOD; LOCOREGIONAL CONTROL; MEAN DOSE; MEDIAN RADIATION; NASAL NK/T-CELL LYMPHOMA; NORMAL STRUCTURE; OVERALL SURVIVAL; PAROTID GLANDS; PLANNING TARGET VOLUMES; PROGNOSIS; PROGRESSION FREE SURVIVAL; TARGET VOLUMES; TREATMENT OUTCOMES;

CELLS; CHEMOTHERAPY; DOSIMETRY; ONCOLOGY; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; DRY EYE; DYSPHAGIA; FEMALE; FEVER; FOLLOW UP; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KAPLAN MEIER METHOD; LOCAL RECURRENCE FREE SURVIVAL; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NASAL NK T CELL LYMPHOMA; NATURAL KILLER T CELL; NK T CELL LYMPHOMA; NOSE CANCER; OVERALL SURVIVAL; PAROTID GLAND; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SKIN MANIFESTATION; TREATMENT OUTCOME; TREATMENT PLANNING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; NOSE NEOPLASMS; ORGANS AT RISK; PAROTID GLAND; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84863011945     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.039     Document Type: Article

References (32)

1. Q. Liang, Z.Y. Ye, and Z.L. Su Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms Chin J Pathol 39 2010 291 295
2. J. Lee, C. Suh, and Y.H. Park Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study J Clin Oncol 24 2006 612 618
3. T.M. Kim, S.Y. Lee, and Y.K. Jeon Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: A national survey of the Korean Cancer Study Group Ann Oncol 19 2008 1477 1484
4. W.Y. Au, D.D. Weisenburger, and T. Intragumtornchai Clinical differences between nasal and extranasal NK/T-cell lymphoma: A study of 136 cases from the International Peripheral T-cell Lymphoma Project Blood 113 2009 3931 3937
5. Y.X. Li, B. Yao, and J. Jin Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma J Clin Oncol 24 2006 181 189
6. Y.X. Li, H. Fang, and Q.F. Liu Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring Blood 112 2008 3057 3064
7. Y.X. Li, Q.F. Liu, and H. Fang Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma Clin Cancer Res 15 2009 2905 2912
8. A. Aviles, N.R. Diaz, and N. Neri Angiocentric nasal T/natural killer cell lymphoma: A single center study of prognostic factors in 108 patients Clin Lab Haematol 22 2000 215 220
9. H.H. Ma, L.T. Qian, and H.F. Pan Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma Med Oncol 27 2010 798 806
10. Z.Y. Wang, Y.X. Li, and W.H. Wang Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents Blood 114 2009 4771 4776
11. M.J. Huang, Y. Jiang, and W.P. Liu Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract Int J Radiat Oncol Biol Phys 70 2008 166 174
12. G.E. Kim, S.W. Lee, and S.K. Chang Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck Radiother Oncol 61 2001 261 269
13. K. Kim, E.K. Chie, and C.W. Kim Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: Radiotherapy versus chemoradiotherapy Jpn J Clin Oncol 35 2005 1 5
14. J.Y. You, K.H. Chi, and M.H. Yang Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: A single institute survey in Taiwan Ann Oncol 15 2004 618 625
15. C.S. Chim, S.Y. Ma, and W.Y. Au Primary nasal natural killer cell lymphoma: Long-term treatment outcome and relationship with the international prognostic index Blood 103 2004 216 221
16. C.C. Li, H.F. Tien, and J.L. Tang Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma Cancer 100 2004 366 375
17. P. Dirix, B. Vanstraelen, and M. Jorissen Intensity-modulated radiotherapy for sinonasal cancer: Improved outcome compared to conventional radiotherapy Int J Radiat Oncol Biol Phys 78 2010 998 1004
18. E.H.N. Pow, D.L.W. Kwong, and A.S. McMillan Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial Int J Radiat Oncol Biol Phys 66 2006 981 991
19. M.K.M. Kam, S.F. Leung, and B. Zee Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients J Clin Oncol 25 2007 4873 4879
20. J.K.C. Chan, L. Quintanilla-Martinez, and J.A. Ferry Extranodal NK/T-cell lymphoma, nasal type E.S. Jaffe, N.L. Harris, H. Stein, World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues 2008 IARC Press Lyon, France 285 288
21. M.A. Shipp, D.P. Harrington, and J.R. Anderson A predictive model for aggressive non-Hodgkin's lymphoma N Engl J Med 329 1993 987 994
22. J.D. Cox, J. Stetz, and T.F. Pajak Toxicity of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
23. M.M. Cheung, J.K. Chan, and W.H. Lau Early stage nasal T/NK-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys 54 2002 182 190
24. N. Tomita, T. Kodaira, and H. Tachiban A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma Br J Radiol 82 2009 756 763
25. P. Dirix, S. Nuyts, and B. Vanstraelen Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses Radiother Oncol 85 2007 385 391
26. B.S. Hoppe, S.L. Wolden, and M.J. Zelefsky Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity Head Neck 30 2008 925-923
27. M.E. Daly, A.M. Chen, and M.K. Bucci Intensity-modulated radiotherapy (IMRT) for malignancies of the nasal cavity and paranasal sinuses Int J Radiat Oncol Biol Phys 67 2007 151 157
28. M. Yamaguchi, K. Tobinai, and M. Oguchi Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211 J Clin Oncol 27 2009 5594 5600
29. S.J. Kim, K. Kim, and B.S. Kim Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-cell lymphoma: Consortium for improving survival of lymphoma study J Clin Oncol 27 2009 6027 6032
30. G.E. Kim, J.H. Cho, and W.I. Yang Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment J Clin Oncol 18 2000 54 63
31. W.S. Koom, E.J. Chung, and W.I. Yang Angiocentric T-cell and NK/T-cell lymphomas: Radiotherapeutic viewpoints Int J Radiat Oncol Biol Phys 59 2004 1127 1137
32. K. Isobe, T. Uno, and J.I. Tamaru Extranodal natural killer/T-cell lymphoma, nasal type Cancer 106 2006 609 615